1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TRAVERE THERAPEUTICS INC
Travere Therapeutics Inc
XNAS: TVTX

Travere Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is...

Read More
44.80 -0.11 (-0.24%)
New 52W High today
3.3M
XNAS Volume

XNAS 05 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Travere Therapeutics Inc is on 15 May 2026 for the purpose of Travere Therapeutics Inc Annual General Meeting for 2026 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
9.8 / 100
Momentum Score
Technically Bullish
71.0 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
53
1Yr Price target upside is 18%
14 analysts

25

S

6

W

6

O

1

T

SWOT Analysis

Travere Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..